Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v7.3)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-9

Query Trace: Thrombosis and meta-analysis and CYP2C19[original query]

CYP2C19 genotype has a greater effect on adverse cardiovascular outcomes following percutaneous coronary intervention and in Asian populations treated with clopidogrel: a meta-analysis. Circulation. Cardiovascular genetics 2014 Dec 7 (6): 895-902. Sorich Michael J, Rowland Andrew, McKinnon Ross A, Wiese Michael Similar articles in PubMed
Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects. Archives of cardiovascular diseases 2013 Oct 106 (10): 517-27. Mao Liu, Jian Chen, Changzhi Liu, Dan Huang, Suihua Huang, Wenyi Tang, Wei Similar articles in PubMed
Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel. The American journal of cardiology 2012 Aug 110 (4): 502-8. Jang Jae-Sik, Cho Kyoung-Im, Jin Han-Young, Seo Jeong-Sook, Yang Tae-Hyun, Kim Dae-Kyeong, Kim Dong-Soo, Seol Sang-Hoon, Kim Doo-Il, Kim Bo-Hyun, Park Yong Hyun, Je Hyung-Gon, Jeong Young-Hoon, Lee Seung-Wh Similar articles in PubMed
The Gain-of-Function Variant Allele CYP2C19*17: A Double-Edged Sword Between Thrombosis and Bleeding in Clopidogrel-Treated Patients. Journal of thrombosis and haemostasis : JTH 2011 Nov . Li Y, Tang HL, Hu YF, Xie HG Similar articles in PubMed
Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis. The pharmacogenomics journal 2011 Jun 11 (3): 199-206. Sofi F, Giusti B, Marcucci R, Gori A M, Abbate R, Gensini G Similar articles in PubMed
Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel. Heart (British Cardiac Society) 2011 Jun . Zabalza M, Subirana I, Sala J, Lluis-Ganella C, Lucas G, Tomás M, Masiá R, Marrugat J, Brugada R, Elosua R Similar articles in PubMed
Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel. Molecular biology reports 2011 Mar 38 (3): 1697-702. Jin Bo, Ni Huan-Chun, Shen Wei, Li Jian, Shi Hai-Ming, Li Yo Similar articles in PubMed
Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis. BMJ (Clinical research ed.) 2011 343 d4588. Bauer Tim, Bouman Heleen J, van Werkum Jochem W, Ford Neville F, ten Berg Jurriën M, Taubert Di Similar articles in PubMed
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis. Journal of the American College of Cardiology 2010 Jul 56 (2): 134-43. Hulot Jean-Sébastien, Collet Jean-Philippe, Silvain Johanne, Pena Ana, Bellemain-Appaix Anne, Barthélémy Olivier, Cayla Guillaume, Beygui Farzin, Montalescot Gill Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Oct 1, 2020
Page last updated:Apr 14, 2021
Content source:

TOP